-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NXmNQ4A885YuNNwMc9TJ9Io8zYLZ4KDOZYTdgTOOTR8oG45+0s157XKPWfYNP7OY VBQoWJbzliRDiEe8CZ2XGg== 0000950135-04-003085.txt : 20040614 0000950135-04-003085.hdr.sgml : 20040611 20040614154313 ACCESSION NUMBER: 0000950135-04-003085 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040614 GROUP MEMBERS: ABINGWORTH BIOVENTURES III A L.P. GROUP MEMBERS: ABINGWORTH BIOVENTURES III B L.P. GROUP MEMBERS: ABINGWORTH BIOVENTURES III C L.P GROUP MEMBERS: ABINGWORTH BIOVENTURES III EXECUTIVES L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79884 FILM NUMBER: 04861456 BUSINESS ADDRESS: STREET 1: 790 MEMORIAL DR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172520700 MAIL ADDRESS: STREET 1: 790 MEMORIAL DR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Abingworth Management LTD CENTRAL INDEX KEY: 0001291892 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN BUSINESS PHONE: 44 20 7534 1508 MAIL ADDRESS: STREET 1: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN SC 13G 1 b50875amsc13g.txt ALNYLAM PHARMACEUTICALS, INC. UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION ------------------------- WASHINGTON, D.C. 20549 OMB Number: 3235-0145 Expires: December 31, 2005 Estimated average burden hours per response.. 14.9 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. __)* Alnylam Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 02043Q107 --------------------------------- (CUSIP Number) June 3, 2004 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 13 pages EXHIBIT 1 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Abingworth Management Limited ("Abingworth Management") - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION England - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 2,343,159 shares, of which 1,176,268 shares are directly owned by ABV III A, 718,031 shares are directly owned by ABV III B, 430,117 shares are directly owned by ABV III C and 18,743 shares are directly owned by ABV III Executives. Abingworth Management, the manager of ABV III A, ABV III B, ABV III C and ABV III Executives may be deemed to have sole power to vote these shares. NUMBER OF --------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY See response in row 5 EACH --------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 2,343,159 shares, of which 1,176,268 shares WITH are directly owned by ABV III A, 718,031 shares are directly owned by ABV III B, 430,117 shares are directly owned by ABV III C and 18,743 shares are directly owned by ABV III Executives. Abingworth Management, the manager of ABV III A, ABV III B, ABV III C and ABV III Executives may be deemed to have sole power to dispose of these shares. --------------------------------------------------------- 8 SHARED DISPOSITIVE POWER See response in row 7. - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,343,159 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- Page 2 of 13 pages - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 12.2% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO - -------------------------------------------------------------------------------- Page 3 of 13 pages EXHIBIT 1 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Abingworth Bioventures III A L.P. ("ABV III A") - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)[ ] (b)[ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION England - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 1,176,268 shares, except that Abingworth Management, the manager of ABV III A, may be deemed to have sole power to vote these shares. NUMBER OF --------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY See response to row 5. EACH --------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 1,176,268 shares, except that Abingworth Management, WITH the manager of ABV III A, may be deemed to have sole power to dispose of these shares. --------------------------------------------------------- 8 SHARED DISPOSITIVE POWER See response to row 7. - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,343,159 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 12.2% - -------------------------------------------------------------------------------- Page 4 of 13 pages - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 5 of 13 pages EXHIBIT 1 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Abingworth Bioventures III B L.P. ("ABV III B") - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION England - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 718,031 shares, except that Abingworth Management, the manager of ABV III B, may be deemed to have sole power to vote these shares. NUMBER OF -------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY See response to row 5. EACH -------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 718,031 shares, except that Abingworth Management, the WITH manager of ABV III B, may be deemed to have sole power to dispose of these shares. -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER See response to row 7. - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,343,159 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 12.2% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 6 of 13 pages - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Abingworth Bioventures III C L.P. ("ABV III C") - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION England - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 430,117 shares, except that Abingworth Management, the manager of ABV III C, may be deemed to have sole power to vote these shares. NUMBER OF -------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY See response to row 5. EACH -------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 430,117 shares, except that Abingworth Management, the WITH manager of ABV III C, may be deemed to have sole power to dispose of these shares. -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER See response to row 7. - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,343,159 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 12.2% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 7 of 13 pages EXHIBIT 1 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Abingworth Bioventures III Executives L.P. ("ABV III Executives") - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 18,743 shares, except that Abingworth Management, the manager of ABV III Executives, may be deemed to have sole power to vote these shares. NUMBER OF -------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY See response to row 5. EACH -------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 18,743 shares, except that Abingworth Management, the WITH manager of ABV III Executives, may be deemed to have sole power to dispose of these shares. -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER See response to row 7. - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,343,159 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 12.2% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 8 of 13 pages Item 1(a). Name of Issuer: Alnylam Pharmaceuticals, Inc. (the "Issuer") Item 1(b). Address of Issuer's Principal Executive Offices: 300 Third Street, Cambridge, Massachusetts 02142 Item 2(a). Name of Person Filing: Abingworth Management Limited ("Abingworth Management"), Abingworth Bioventures III A L.P. ("ABV III A"), Abingworth Bioventures III B L.P. ("ABV III B"), Abingworth Bioventures III C L.P. ("ABV III C"), and Abingworth Bioventures III Executives L.P. ("ABV III Executives"). The foregoing individuals are collectively referred to as the "Reporting Persons." Abingworth Management, the manager of ABV III A, ABV III B, ABV III C and ABV III Executives, may be deemed to have sole power to vote and sole power to dispose of shares of the Issuer directly owned by ABV III A, ABV III B, ABV III C and ABV III Executives. Item 2(b). Address of Principal Business Office or, if None, Residence: The business address for Abingworth Management, ABV III A, ABV III B, ABV III C and ABV III Executives is c/o Abingworth Management Limited, Princes House, 38 Jermyn Street, London, England SW1Y 6DN. Item 2(c). Citizenship: Abingworth Management is a corporation organized under the laws of England. ABV III A, ABV III B and ABV III C are limited partnerships organized under the laws of England. ABV III Executives is a limited partnership organized under the laws of Delaware. Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 02043Q107 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: Not applicable. Item 4. Ownership. Page 9 of 13 pages EXHIBIT 1 The following information with respect to the ownership of the Common Stock of the Issuer by the persons filing this Statement is provided as of June 3, 2004: (a) Amount beneficially owned: See row 9 of cover page for each Reporting Person. (b) Percent of Class: See row 11 of cover page for each Reporting Person. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See row 5 of cover page for each Reporting Person. (ii) Shared power to vote or to direct the vote: See row 6 of cover page for each Reporting Person. (iii) Sole power to dispose or to direct the disposition: See row 7 of cover page for each Reporting Person. (iv) Shared power to dispose or to direct the disposition: See row 8 of cover page for each Reporting Person. Each of Abingworth Management, ABV III A, ABV III B, ABV III C and ABV III Executives, expressly disclaims beneficial ownership of any shares of Common Stock of the Issuer except, in the case of ABV III A, for the 1,176,268 shares of Common Stock that it holds of record, in the case of ABV III B, for the 718,031 shares of Common Stock that it holds of record, in the case of ABV III C, for the 430,117 shares of Common Stock that it holds of record, and in the case of ABV III Executives, for the 18,743 shares of Common Stock that it holds of record. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Page 10 of 13 pages Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 11 of 13 pages EXHIBIT 1 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: June 14, 2004 ABINGWORTH MANAGEMENT LIMITED /s/ James Abell By:______________________________ Name: James Abell Title: Executive Director ABINGWORTH BIOVENTURES III A L.P. By: Abingworth Management Limited, its Manager /s/ James Abell By:_______________________________ Name: James Abell Title: Executive Director ABINGWORTH BIOVENTURES III B L.P. By: Abingworth Management Limited, its Manager /s/ James Abell By:_______________________________ Name: James Abell Title: Executive Director ABINGWORTH BIOVENTURES III C L.P. By: Abingworth Management Limited, its Manager /s/ James Abell By:_______________________________ Name: James Abell Title: Executive Director Page 12 of 13 pages ABINGWORTH BIOVENTURES III EXECUTIVES L.P. By: Abingworth Management Limited, its Manager /s/ James Abell By:_______________________________ Name: James Abell Title: Executive Director Page 13 of 13 pages EXHIBIT 1 AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13 need be filed with respect to the ownership by each of the undersigned of shares of stock of Alnylam Pharmaceuticals, Inc. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original. EXECUTED this 14th day of June, 2004. ABINGWORTH MANAGEMENT LIMITED /s/ James Abell By:_______________________________ Name: James Abell Title: Executive Director ABINGWORTH BIOVENTURES III A L.P. By: Abingworth Management Limited, its Manager /s/ James Abell By:_______________________________ Name: James Abell Title: Executive Director ABINGWORTH BIOVENTURES III B L.P. By: Abingworth Management Limited, its Manager /s/ James Abell By:_______________________________ Name: James Abell Title: Executive Director ABINGWORTH BIOVENTURES III C L.P. By: Abingworth Management Limited, its Manager /s/ James Abell By:_______________________________ Name: James Abell Title: Executive Director ABINGWORTH BIOVENTURES III EXECUTIVES L.P. By: Abingworth Management Limited, its Manager /s/ James Abell By:_______________________________ Name: James Abell Title: Executive Director -----END PRIVACY-ENHANCED MESSAGE-----